Our results were consistent with previous studies on the prognostic value of SATB1 expression in other malignancies [42–44] and thus further provide additional support for the concept that the regulatory activities of SATB1 in cancer preferentially seem to confer a more malignant phenotype [45]. Here, SATB1 is linked to cancer.